Compare, Analyse Wockhardt with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ACTAVIS (US) - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT   ACTAVIS
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
ACTAVIS
Dec-18
WOCKHARDT/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,01214,764-   
Low Rs5329,904-   
Sales per share (Unadj.) Rs355.93,621.6-  
Earnings per share (Unadj.) Rs-60.3-1,166.5-  
Cash flow per share (Unadj.) Rs-46.8381.6-  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.814,937.5-  
Shares outstanding (eoy) m110.63332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.23.4 63.7%   
Avg P/E ratio x-12.8-10.6 121.1%  
P/CF ratio (eoy) x-16.532.3 -51.1%  
Price / Book Value ratio x3.00.8 362.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,3794,102,253 2.1%   
No. of employees `0006.316.9 37.0%   
Total wages/salary Rs m9,3710-   
Avg. sales/employee Rs Th6,295.071,275.0 8.8%   
Avg. wages/employee Rs Th1,498.30-   
Avg. net profit/employee Rs Th-1,066.3-22,957.7 4.6%   
INCOME DATA
Net Sales Rs m39,3691,204,548 3.3%  
Other income Rs m1,20223,035 5.2%   
Total revenues Rs m40,5711,227,583 3.3%   
Gross profit Rs m1831,565 0.1%  
Depreciation Rs m1,495514,918 0.3%   
Interest Rs m2,55569,509 3.7%   
Profit before tax Rs m-2,830-529,827 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,582135,127 -2.7%   
Tax Rs m257-6,714 -3.8%   
Profit after tax Rs m-6,669-387,986 1.7%  
Gross profit margin %02.6 1.8%  
Effective tax rate %-9.11.3 -716.7%   
Net profit margin %-16.9-32.2 52.6%  
BALANCE SHEET DATA
Current assets Rs m33,796494,043 6.8%   
Current liabilities Rs m26,917437,046 6.2%   
Net working cap to sales %17.54.7 369.3%  
Current ratio x1.31.1 111.1%  
Inventory Days Days7920 405.1%  
Debtors Days Days8966 134.6%  
Net fixed assets Rs m39,664136,348 29.1%   
Share capital Rs m5530-   
"Free" reserves Rs m27,9680-   
Net worth Rs m28,5224,968,198 0.6%   
Long term debt Rs m21,7311,749,483 1.2%   
Total assets Rs m81,6207,766,424 1.1%  
Interest coverage x-0.1-6.6 1.6%   
Debt to equity ratio x0.80.4 216.4%  
Sales to assets ratio x0.50.2 311.0%   
Return on assets %-5.0-4.1 122.9%  
Return on equity %-23.4-7.8 299.4%  
Return on capital %-7.7-4.8 158.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,0190-   
CASH FLOW
From Operations Rs m684430,340 0.2%  
From Investments Rs m6,302236,416 2.7%  
From Financial Activity Rs m-7,695-738,592 1.0%  
Net Cashflow Rs m-664-71,478 0.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 76.3 Rs / USD

Compare WOCKHARDT With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare WOCKHARDT With: IPCA LABS  DIVIS LABORATORIES  ALEMBIC PHARMA  GLENMARK PHARMA  NATCO PHARMA  



Today's Market

Nifty Below 8,300 Mark, Fiscal Deficit in Feb, Maruti Suzuki Sales, and Top Cues in Focus Today(Pre-Open)

Indian share markets extended losses in the first trading session of FY21 on Wednesday. Losses were seen as the number of coronavirus cases in the country continued to rise.

Related Views On News

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout... (The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

WOCKHARDT SHARE PRICE


Apr 1, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

OTHER USEFUL LINKS

MARKET STATS